Posts

Showing posts with the label which is meant for high-risk Covid patients early in their illness.

A monoclonal antibody drug from Eli Lilly that has promise against Omicron gets emergency authorization.

Image
By BY SHERYL GAY STOLBERG AND REBECCA ROBBINS from NYT World https://ift.tt/O6AL4a0 via IFTTT